Alirocumab (anti-PCSK9)
CAT:
804-HY-P9928A-02
Size:
1 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: Yes
Alirocumab (anti-PCSK9)
- CAS Number: 9007-83-4
- UNSPSC Description: Alirocumab (anti-PCSK9) is a human monoclonal antibody inhibiting proprotein convertase subtilisin/kexin type 9 (PCSK9). Alirocumab specifically binds PCSK9, a down regulator of liver low-density lipoprotein (LDL)-receptors, thereby increasing the ability of the liver to bind LDL-cholesterol (LDL-C) and reducing levels of LDL-C in blood. Alirocumab can be used for the research of hypercholesterolemia[1][2].
- Target Antigen: PCSK9
- Type: Inhibitory Antibodies
- Related Pathways: Metabolic Enzyme/Protease
- Applications: Neuroscience-Neuromodulation
- Field of Research: Cardiovascular Disease; Cancer
- Assay Protocol: https://www.medchemexpress.com/alirocumab-anti-pcsk9.html
- Purity: 98.24
- Solubility: H2O
- Smiles: [Alirocumab (anti-PCSK9)]
- References & Citations: [1]Markham A. Alirocumab: First Global Approval. Drugs. 2015;75(14):1699-1705.|[2]Tavori H, et al. Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction. Expert Rev Cardiovasc Ther. 2014 Oct;12(10):1137-44.
- Shipping Conditions: Dry Ice
- Storage Conditions: Store at -80°C for 2 years
- Clinical Information: Phase 4